Gaxos.ai (NASDAQ:GXAI – Get Free Report) and Cencora (NYSE:COR – Get Free Report) are both healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their valuation, institutional ownership, profitability, earnings, dividends, risk and analyst recommendations.
Valuation and Earnings
This table compares Gaxos.ai and Cencora”s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Gaxos.ai | $1.93 million | 2.29 | -$3.90 million | ($0.44) | -0.94 |
| Cencora | $638.56 million | 107.30 | $3.48 billion | $17.92 | 20.04 |
Cencora has higher revenue and earnings than Gaxos.ai. Gaxos.ai is trading at a lower price-to-earnings ratio than Cencora, indicating that it is currently the more affordable of the two stocks.
Institutional & Insider Ownership
42.6% of Gaxos.ai shares are held by institutional investors. Comparatively, 97.5% of Cencora shares are held by institutional investors. 3.2% of Gaxos.ai shares are held by insiders. Comparatively, 0.4% of Cencora shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
Analyst Recommendations
This is a breakdown of recent recommendations and price targets for Gaxos.ai and Cencora, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Gaxos.ai | 1 | 0 | 0 | 0 | 1.00 |
| Cencora | 0 | 4 | 12 | 0 | 2.75 |
Cencora has a consensus target price of $368.14, indicating a potential upside of 2.53%. Given Cencora’s stronger consensus rating and higher probable upside, analysts clearly believe Cencora is more favorable than Gaxos.ai.
Volatility & Risk
Gaxos.ai has a beta of 1.13, indicating that its share price is 13% more volatile than the S&P 500. Comparatively, Cencora has a beta of 0.58, indicating that its share price is 42% less volatile than the S&P 500.
Profitability
This table compares Gaxos.ai and Cencora’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Gaxos.ai | -46.46% | -35.92% | -33.94% |
| Cencora | 1.03% | 110.72% | 4.22% |
Summary
Cencora beats Gaxos.ai on 12 of the 14 factors compared between the two stocks.
About Gaxos.ai
Gaxos.ai Inc. is a technology company focused on developing artificial intelligence applications. The company was formerly known as The NFT Gaming Company and adopted the Gaxos.ai name as it expanded its focus beyond digital gaming. Its Gaxos Labs business develops generative AI tools for video game creators, designed to help produce digital content such as characters and other in-game assets. Gaxos.ai has also described efforts to develop AI applications for health and wellness. The company’s activities center on applying AI technology to gaming and other consumer-facing applications.
About Cencora
Cencora, formerly known as AmerisourceBergen, is a global pharmaceutical services company that connects pharmaceutical manufacturers with healthcare providers. Its core business includes sourcing and distributing medicines and other healthcare products to pharmacies, hospitals, health systems and other care providers. The company also provides services supporting specialty pharmaceuticals, including logistics, consulting and solutions for manufacturers and healthcare organizations. These services help manage the handling and delivery of complex medicines and support access to treatments.
Receive News & Ratings for Gaxos.ai Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gaxos.ai and related companies with MarketBeat.com's FREE daily email newsletter.
